1s17: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1s17" size="450" color="white" frame="true" align="right" spinBox="true" caption="1s17, resolution 1.95Å" /> '''Identification of No...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1s17.gif|left|200px]]<br /><applet load="1s17" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1s17.gif|left|200px]]<br /><applet load="1s17" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1s17, resolution 1.95&Aring;" />
caption="1s17, resolution 1.95&Aring;" />
'''Identification of Novel Potent Bicyclic Peptide Deformylase Inhibitors'''<br />
'''Identification of Novel Potent Bicyclic Peptide Deformylase Inhibitors'''<br />


==Overview==
==Overview==
Screening of our compound collection using Staphylococcus aureus, Ni-Peptide deformylase (PDF) afforded a very potent PDF inhibitor with an, IC(50) in the low nanomolar range but with poor antibacterial activity, (MIC). Three-dimensional structural information obtained from Pseudomonas, aeruginosa Ni-PDF complexed with the inhibitor suggested the synthesis of, a variety of analogues that would maintain high binding affinity while, attempting to improve antibacterial activity. Many of the compounds, synthesized proved to be excellent PDF-Ni inhibitors and some showed, increased antibacterial activity in selected strains.
Screening of our compound collection using Staphylococcus aureus Ni-Peptide deformylase (PDF) afforded a very potent PDF inhibitor with an IC(50) in the low nanomolar range but with poor antibacterial activity (MIC). Three-dimensional structural information obtained from Pseudomonas aeruginosa Ni-PDF complexed with the inhibitor suggested the synthesis of a variety of analogues that would maintain high binding affinity while attempting to improve antibacterial activity. Many of the compounds synthesized proved to be excellent PDF-Ni inhibitors and some showed increased antibacterial activity in selected strains.


==About this Structure==
==About this Structure==
1S17 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Pseudomonas_aeruginosa Pseudomonas aeruginosa] with NI, GNR and GOL as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Peptide_deformylase Peptide deformylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.1.88 3.5.1.88] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1S17 OCA].  
1S17 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Pseudomonas_aeruginosa Pseudomonas aeruginosa] with <scene name='pdbligand=NI:'>NI</scene>, <scene name='pdbligand=GNR:'>GNR</scene> and <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Peptide_deformylase Peptide deformylase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.5.1.88 3.5.1.88] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1S17 OCA].  


==Reference==
==Reference==
Line 22: Line 22:
[[Category: Molteni, V.]]
[[Category: Molteni, V.]]
[[Category: Nabakka, J.]]
[[Category: Nabakka, J.]]
[[Category: Ryder, N.S.]]
[[Category: Ryder, N S.]]
[[Category: Yang, K.]]
[[Category: Yang, K.]]
[[Category: GNR]]
[[Category: GNR]]
Line 32: Line 32:
[[Category: rational drug design]]
[[Category: rational drug design]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 02:01:41 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:56:57 2008''